0.00Open0.00Pre Close0 Volume0 Open Interest119.00Strike Price0.00Turnover770.99%IV-92.68%PremiumApr 25, 2025Expiry Date57.24Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9747Delta0.0031Gamma1.08Leverage Ratio-0.8610Theta-0.0015Rho-1.05Eff Leverage0.0015Vega
Sarepta Therapeutics Stock Discussion
Sarepta Expands Rare Disease Pipeline: FDA Green Light for New LGMD Trial
The Nasdaq gained 316.1 points (1.4%) to 17,750.79, the S&P 500 added 60.63 ticks (1.1%) to 5,675.29 and the DJIA rose 383.32 points (0.9%) to 41,964.63 after the Fed...
The $Nasdaq Composite Index (.IXIC.US)$ shed 304.54 points (1.7%) to a 17,504.12 close, while the $S&P 500 Index (.SPX.US)$ gave up 60.45 ticks (1.1%) to 5,614.66 and the $Dow Jones Industrial Average (.DJI.US)$ lost 260....
No comment yet